.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
At last year's ESMO conference, there was hope that the TIGIT field still had a ...
Today on Post Hoc Live, Drew Armstrong is joined by Nick Shipley, the former top...
Today on Post Hoc Live, Drew Armstrong is joined by Nick Shipley, the former top...
A month ago, former AbbVie and Neumora executive Henry Gosebruch was named the C...
Bayer has been ramping up its layoff count in recent months as it edges closer t...
The last time Dutch biotech Azafaros disclosed a financing round — a €25 million...
President Donald Trump on Monday made a sweeping promise to bring down drug pric...
The White House's plan to realign US drug prices with similar high-income countr...
The latest version of a massive and wide-ranging tax cut bill includes several p...
Roche said its $50 billion promise to expand its manufacturing footprint in the ...
Stylus Medicine, an ambitious startup founded by Patrick Hsu, has raised $85 mil...
The White House plans to force down prices of drugs sold in the US by threatenin...
The annual meeting of the European Association for the Study of the Liver (EASL)...
Plus, news about CytomX, Valneva, Lenz and Lotus Pharmaceutical:
The White House outlined plans to force down prices of drugs sold in the US usin...
Eli Lilly said Sunday that new data on Zepbound show the GIP/GLP-1 dual agonist ...